The in vitro antitumour activity of the novel complex has been tested and the result shows that the novel complex exhibits better antitumour activity in vitro against HL 60, HCT 8, BGC 823 and KB tumour cells.

• 体外抗癌活性测试结果表明 ；该配合物对人体的白血病HL 60、结肠癌HCT 8、胃癌BGC 82 3和鼻咽癌KB等癌细胞均有很好的抑制能力 .